📰 Celularity Inc News
Page 7 - Celularity Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Celularity Inc. Real-time updates on events, politics, business and more.
May 22, 2023
Exxon Mobil is bracing for a future far less dependent on gasoline by drilling for something other than oil: lithium. The Texas oil giant recently purchased drilling rights to a sizable chunk of Arkansas land from which it aims to produce the miner... | 06:20am
May 19, 2023
19.05.2023 - Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derived mesenchymal-like adherent stem cells (MLASCs) results in alterations in gene and protein ... Seite 1
May 19, 2023
Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derived mesenchymal-like adherent stem cells results in... | June 11, 2023
May 15, 2023
Celularity Inc. (NASDAQ:CELUW – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 8,300 shares, a drop of 40.7% from the April 15th total of 14,000 shares. Based on an average daily volume of 20,000 shares, the days-to-cover […]
May 1, 2023
Celularity Inc. (NASDAQ:CELU – Get Rating) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 3,790,000 shares, a drop of 26.7% from the March 31st total of 5,170,000 shares. Approximately 5.4% of the company’s shares are sold short. Based on an average daily […]
May 1, 2023
Celularity Inc. (NASDAQ:CELUW – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 14,000 shares, an increase of 30.8% from the March 31st total of 10,700 shares. Based on an average daily volume of 20,500 shares, the short-interest […]
April 26, 2023
Inhibitor Therapeutics (OTCMKTS:INTI – Get Rating) and Celularity (NASDAQ:CELU – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Risk and Volatility Inhibitor Therapeutics has a beta of -0.46, […]
April 22, 2023
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, an increase of 8.8% from the March 15th total of 4,750,000 shares. Based on an average daily volume of 570,100 shares, the days-to-cover […]
April 20, 2023
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]
April 7, 2023
Item 1.01 Entry into a Material Definitive Agreement. Registered Direct Offering On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional... | April 7, 2023